Evidence map›Paper›PMID 30521836›Full record

ArticleThe Journal of investigative dermatology2019

Are Environmental Factors for Atopic Eczema in ISAAC Phase Three due to Reverse Causation?

Charlotte E Rutter, Richard J Silverwood, Hywel C Williams, Philippa Ellwood, Innes Asher, Luis Garcia-Marcos, David P Strachan, Neil Pearce, Sinéad M Langan, ISAAC Phase Three Study Group

Abstract readComparative Study
In one paragraph

Article in The Journal of investigative dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Environmental risk factors for allergic rhinitis differ by income level: A Global Asthma Network survey.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  3. Article
  4. Review
  5. Environmental Influences on Atopic Eczema.Journal of environmental science and public health · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Recent advances in atopic dermatitis.Current opinion in immunology · 2020
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Charlotte E RutterFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Richard J SilverwoodFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Hywel C WilliamsCentre of Evidence-Based Dermatology, University of Nottingham, Nottingham, UK.
Philippa EllwoodDepartment of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand.
Innes AsherDepartment of Paediatrics: Child and Youth Health, University of Auckland, Auckland, New Zealand.
Luis Garcia-MarcosPediatric Allergy and Pulmonology Units, Virgen de la Arrixaca University Children's Hospital, University of Murcia and IMIB Bioresearch Institute, Murcia, Spain.
David P StrachanPopulation Health Research Institute, St George's University of London, London, UK.
Neil PearceFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK; Red de Asma, Reacciones Adversas y Alérgicas, Madrid, Spain; Centre for Public Health Research, Massey University, Wellington, New Zealand.
Sinéad M LanganFaculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK. Electronic address: Sinead.langan@lshtm.ac.uk.
ISAAC Phase Three Study Group

Funding

Medical Research Council MR/N013638/1Wellcome Trust 205039/Z/16/ZWellcome Trust MR/N013638/1
6 · The paper itself

Abstract

Some previously described environmental associations for atopic eczema may be due to reverse causation. We explored the role of reverse causation by comparing individual- and school-level results for multiple atopic eczema risk factors. The International Study of Asthma and Allergies in Childhood (i.e, ISAAC) Phase Three surveyed children in schools (the sampling unit) regarding atopic eczema symptoms and potential risk factors. We assessed the effect of these risk factors on atopic eczema symptoms using mixed-effect logistic regression models, first with individual-level exposure data and second with school-level exposure prevalence. Overall, 546,348 children from 53 countries were included. At ages 6-7 years, the strongest individual-level associations were with current paracetamol use (odds ratio [OR] = 1.45, 95% confidence interval [CI] = 1.37-1.54), which persisted at school-level (OR = 1.55, 95% CI = 1.10-2.21), early-life antibiotics (OR = 1.41, 95% CI = 1.34-1.48), and early-life paracetamol use (OR = 1.28, 95% CI = 1.21-1.36), with the former persisting at the school level, whereas the latter was no longer observed (OR = 1.35, 95% CI = 1.00-1.82 and OR = 0.94, 95% CI = 0.69-1.28, respectively). At ages 13-14 years, the strongest associations at the individual level were with current paracetamol use (OR = 1.57, 95% CI = 1.51-1.63) and open-fire cooking (OR = 1.46, 95% CI = 1.33-1.62); both were stronger at the school level (OR = 2.57, 95% CI = 1.84-3.59 and OR = 2.38, 95% CI = 1.52-3.73, respectively). Association with exposure to heavy traffic (OR = 1.31, 95% CI = 1.27-1.36) also persisted at the school level (OR = 1.40, 95% CI = 1.07-1.82). Most individual- and school-level effects were consistent, tending to exclude reverse causation.

Indexed as

School Health ServicesAcetaminophenAdolescentAge FactorsCausalityChildConfidence IntervalsDermatitis, AtopicEczemaEnvironmental ExposureFemaleHumansInternationalityLogistic ModelsMalePrevalenceAcetaminophen

Identifiers

PMID30521836
PMCPMC6478380

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.